Media Advisory - Canopy Growth Presents Flower Forward: The Future of Cannabis
TORONTO, Nov. 21, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") will host an exclusive, immersive event on November 28th, 2019 for a sneak peek at new cannabis-infused products set to launch in Canada starting next month.
Media are invited to join Canopy Growth executives and representatives for a detailed rundown of Canopy's "Cannabis 2.0" lineup - including premium chocolate, a line of distilled cannabis beverages, and a range of vape cartridges and pens.
What to expect:
A keynote speech delivered by Canopy Growth President, Rade Kovacevic, detailing our path forward for Cannabis 2.0
A presentation by Canopy Growth Chief Technology Officer Peter Popplewell unveiling our state-of-the-art vape technology
Interactive Showcases for each new product category hosted by our innovation experts
An exclusive opportunity to be among the first to touch, taste and trial inactive samples of our product portfolio
Event details:
Date: November 28, 2019 Registration: 12:30pm Event Begins: 1pm Location:Design Exchange, 234 Bay Street, Toronto RSVP: If you're planning on attending, please RSVP here (media only, please)
Please note that you must RSVP in order to be admitted to the event.
As part of Tampa General Hospital's (TGH) commitment to transforming health care through innovation, the academic health system collaborated with Manatee County and Archer First Response Systems (ArcherFRS) to accelerate response times to...
Today, Professor Francesco Muntoni, principal investigator of the international multicenter gene therapy trial for Duchenne Muscular Dystrophy with GNT0004 product, sponsored by Genethon, presented the innovative trial design and its initial results...
In this free webinar, attendees will gain insights into the clinical trial landscapes in China and Australia and discover practical strategies for maximizing collaboration and ensuring successful outcomes. This includes identifying common areas of...
Engage, Powered by ENA, on Tuesday announced a new partnership with Golisano Children's Hospital of Southwest Florida's emergency department that centers on enhancing the well-being and professional growth of emergency nurses who play an integral...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and...
Concert Health, the leading Collaborative Care platform, and the Advancing Integrated Mental Health Solutions (AIMS) Center in the University of Washington Department of Psychiatry and Behavioral Sciences, today announced a three year, multi-state...
